Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 63,712Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3SANOFI-AVENTIS CANADA INC

02 1BIOCON SDN.BHD

03 7NOVO NORDISK CANADA INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

INSULIN ASPART

Brand Name : TRURAPI

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging :

Approval Date :

Application Number : 2506564

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

02

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

INSULIN ASPART

Brand Name : TRURAPI

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging :

Approval Date :

Application Number : 2506572

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

03

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

INSULIN ASPART

Brand Name : TRURAPI

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging :

Approval Date :

Application Number : 2529254

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

04

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

INSULIN ASPART

Brand Name : NOVORAPID

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 3 ML

Approval Date :

Application Number : 2244353

Regulatory Info : Schedule D

Registration Country : Canada

blank

05

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

INSULIN ASPART

Brand Name : NOVORAPID

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 10 ML

Approval Date :

Application Number : 2245397

Regulatory Info : Schedule D

Registration Country : Canada

blank

06

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

INSULIN ASPART

Brand Name : NOVOMIX 30

Dosage Form : SUSPENSION

Dosage Strength : 30UNIT/ML

Packaging : 3ML

Approval Date :

Application Number : 2265435

Regulatory Info : Schedule D

Registration Country : Canada

blank

07

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

INSULIN ASPART PROTAMINE

Brand Name : NOVOMIX 30

Dosage Form : SUSPENSION

Dosage Strength : 70UNIT/ML

Packaging : 3ML

Approval Date :

Application Number : 2265435

Regulatory Info : Schedule D

Registration Country : Canada

blank

08

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

INSULIN ASPART

Brand Name : FIASP

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 1X10ML

Approval Date :

Application Number : 2460408

Regulatory Info : Schedule D

Registration Country : Canada

blank

09

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

INSULIN ASPART

Brand Name : FIASP

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 5X3ML

Approval Date :

Application Number : 2460416

Regulatory Info : Schedule D

Registration Country : Canada

blank

10

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

INSULIN ASPART

Brand Name : FIASP

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 5X3ML

Approval Date :

Application Number : 2460424

Regulatory Info : Schedule D

Registration Country : Canada

blank